Review of Applications of Cyclodextrins as Taste-Masking Excipients for Pharmaceutical Purposes

被引:26
作者
Adamkiewicz, Lena [1 ]
Szeleszczuk, Lukasz [1 ]
机构
[1] Med Univ Warsaw, Fac Pharm, Dept Organ & Phys Chem, Banacha 1, PL-02093 Warsaw, Poland
关键词
cyclodextrins; taste masking; excipients; electronic tongue; inclusion complexes; HYDROXYPROPYL-BETA-CYCLODEXTRIN; ORAL DISINTEGRATING TABLET; BITTER TASTE; IN-VITRO; ORODISPERSIBLE FILM; DISSOLVING TABLETS; DRY SUSPENSION; FORMULATION; COMPLEXATION; HYDROCHLORIDE;
D O I
10.3390/molecules28196964
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is widely recognized that many active pharmaceutical ingredients (APIs) have a disagreeable taste that affects patient acceptability, particularly in children. Consequently, developing dosage forms with a masked taste has attracted a lot of interest. The application of cyclodextrins as pharmaceutical excipients is highly appreciated and well established, including their roles as drug delivery systems, solubilizers and absorption promoters, agents that improve drug stability, or even APIs. The first work describing the application of the taste-masking properties of CDs as pharmaceutical excipients was published in 2001. Since then, numerous studies have shown that these cyclic oligosaccharides can be effectively used for such purposes. Therefore, the aim of this review is to provide insight into studies in this area. To achieve this aim, a systematic evaluation was conducted, which resulted in the selection of 67 works representing both successful and unsuccessful works describing the application of CDs as taste-masking excipients. Particular attention has been given to the methods of evaluation of the taste-masking properties and the factors affecting the outcomes, such as the choice of the proper cyclodextrin or guest-host molar ratio. The conclusions of this review reveal that the application of CDs is not straightforward; nevertheless, this solution can be an effective, safe, and inexpensive method of taste masking for pharmaceutical purposes.
引用
收藏
页数:33
相关论文
共 89 条
[21]  
FRENCH D, 1957, ADV CARBOHYD CHEM, V12, P189
[22]   Masking mechanisms of bitter taste of drugs studied with ion selective electrodes [J].
Funasaki, Noriaki ;
Uratsuji, Ikumi ;
Okuno, Takashi ;
Hirota, Shun ;
Neya, Saburo .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2006, 54 (08) :1155-1161
[23]  
Gangotia P, 2019, Research Journal of Pharmacy and Technology, V12, P1827, DOI [10.5958/0974-360x.2019.00305.6, 10.5958/0974-360X.2019.00305.6, DOI 10.5958/0974-360X.2019.00305.6]
[24]  
Ganguly I., 2014, IRANIAN J PHARM SCI, V10, P71
[25]   An Overview of Taste-Masking Technologies: Approaches, Application, and Assessment Methods [J].
Hu, Shuqin ;
Liu, Xiaoxuan ;
Zhang, Shuangshuang ;
Quan, Danyi .
AAPS PHARMSCITECH, 2023, 24 (02)
[26]   Formulation and in vitro evaluation of taste-masked oro-dispersible dosage form of diltiazem hydrochloride [J].
Jagdale, Swati Changdeo ;
Gawali, Vaibhav Uttam ;
Kuchekar, Bhanudas Shankar ;
Chabukswar, Aniruddha Rajaram .
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 47 (04) :907-916
[27]   Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression [J].
Kande, Kishor V. ;
Kotak, Darsheen J. ;
Degani, Mariam S. ;
Kirsanov, Dmitry ;
Legin, Andrey ;
Devarajan, Padma V. .
AAPS PHARMSCITECH, 2017, 18 (06) :2055-2066
[28]   Development, characterization and performance evaluation of oro-dispersible tablet containing aceclofenac hydroxypropyl-β-cyclodextrin binary system [J].
Kasliwal, Nikhil ;
Negi, Jeetendra Singh .
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2011, 71 (1-2) :215-224
[29]   Cetirizine Dihydrochloride, β-Cyclodextrin Inclusion Complex by Ethanol Kneading for Taste Masking [J].
Katewongsa, P. ;
Lertsuphotvanit, N. ;
Phaechamud, T. .
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 79 (05) :758-767
[30]  
Kaushik SAKSHI, 2020, International Journal of Applied Pharmaceutics, P107, DOI [10.22159/ijap.2020v12i6.38927, 10.22159/ijap.2020v12i6.38927, DOI 10.22159/IJAP.2020V12I6.38927]